Peroxisome proliferator-activated receptor α/γ dual Agonists for the treatment of type 2 diabetes

被引：130
|
作者：
Henke, BR [1 ]
机构：
[1] GlaxoSmithKline, Metab & Viral Dis Drug Discovery Res, Res Triangle Pk, NC 27709 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 17期
关键词：
D O I：
10.1021/jm030631e
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：4118 / 4127
页数：10
相关论文
共 50 条
  • [21] Peroxisome proliferator-activated receptor gamma agonists: Their role as vasoprotective agents in diabetes
    Blaschke, Florian
    Caglayan, Evren
    Hsueh, Willa A.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2006, 35 (03) : 561 - +
  • [22] Peroxisome proliferator-activated receptor γ in diabetes and metabolism
    Rangwala, SM
    Lazar, MA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) : 331 - 336
  • [23] Selective peroxisome proliferator-activated receptora modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
    Fruchart, Jean-Charles
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [24] From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators
    Dagdelen, Selcuk
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2008, 2 (01) : 24 - 28
  • [25] Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease?
    Zhang, Xin-Yang
    Chen, Qin-Jun-Jie
    Zhu, Feng
    Li, Min
    Shang, Dan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (37)
  • [26] Recent Updates on Peroxisome Proliferator-Activated Receptor Agonists for the Treatment of Metabolic Syndrome
    Grewal, Ajmer S.
    Beniwal, Meenu
    Pandita, Deepti
    Sekhon, Bhupinder S.
    Lather, Viney
    MEDICINAL CHEMISTRY, 2016, 12 (01) : 3 - 21
  • [27] The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
    Thomas, M. C.
    Jandeleit-Dahm, K. A.
    Tikellis, C.
    PPAR RESEARCH, 2012, 2012
  • [28] Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes
    Erdmann, Erland
    Califf, Robert
    Gerstein, Hertzel C.
    Malmberg, Klas
    Ruilope, Luis
    Schwartz, Gregory G.
    Wedel, Hans
    Volz, Dietmar
    Ditmarsch, Marc
    Svensson, Anders
    Bengus, Monica
    AMERICAN HEART JOURNAL, 2015, 170 (01) : 117 - 122
  • [29] The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
    Li, Jingjing
    Guo, Chuanyong
    Wu, Jianye
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2619 - 2628
  • [30] Discovery, design, and synthesis of peroxisome proliferator-activated receptor δ agonists
    Chin, Jungwook
    Lee, Geumwoo
    Hwang, Hoosang
    Kang, Heonjoong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
12345